Affinity, cross-reactivity and biological effectiveness of rabbit antibodies against a synthetic 37 amino acid C-terminal peptide of human chorionic gonadotrophin
- PMID: 6993062
- PMCID: PMC1537952
Affinity, cross-reactivity and biological effectiveness of rabbit antibodies against a synthetic 37 amino acid C-terminal peptide of human chorionic gonadotrophin
Abstract
As a part of a programme to develop a fertility regulating vaccine, antibodies specific for human chorionic gonadotrophin were raised by immunizing rabbits with a synthetic 37 amino acid C-terminal peptide of beta hCG conjugated to tetanus toxoid as carrier, and using Bordetella pertussis or Freund's complete adjuvant as adjuvants. Lack of cross-reactivity of the antibodies with human luteinizing hormone was determined by direct binding in a radioimmunoassay and by immunofluorescence on adult human pituitary sections. Not only did the antibodies bind to native hormone in a radioimmunoassay but they also neutralized the biological activity of hCG as measured by an in vivo bioassay. Rabbits which had been injected with the conjugate with B. pertussis as adjuvant made antibodies of comparable affinity to those animals which had been immunized with the antigen in Freund's complete adjuvant, though the latter group did produce more antibodies.
Similar articles
-
Non-cross-reactive monoclonal antibodies to human chorionic gonadotropin generated after immunization with a synthetic peptide.J Immunol. 1985 Feb;134(2):835-40. J Immunol. 1985. PMID: 2578164
-
Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.Fertil Steril. 1986 Jul;46(1):120-6. doi: 10.1016/s0015-0282(16)49469-0. Fertil Steril. 1986. PMID: 2424791
-
Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.J Mol Recognit. 2004 Nov-Dec;17(6):540-57. doi: 10.1002/jmr.682. J Mol Recognit. 2004. PMID: 15386623
-
Human chorionic gonadotrophin: properties and potential immunological manipulation for clinical application.Clin Obstet Gynaecol. 1979 Dec;6(3):549-66. Clin Obstet Gynaecol. 1979. PMID: 116797 Review.
-
Use of synthetic peptides as immunogens for developing a vaccine against human chorionic gonadotropin.Ciba Found Symp. 1986;119:200-25. doi: 10.1002/9780470513286.ch12. Ciba Found Symp. 1986. PMID: 2426053 Review.
Cited by
-
Basic aspects of immunomodulation through active immunization.Livest Prod Sci. 1995 Jun;42(2):135-145. doi: 10.1016/0301-6226(95)00014-C. Epub 2000 Mar 13. Livest Prod Sci. 1995. PMID: 32287875 Free PMC article.
-
Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.Vaccine. 2007 Jan 5;25(3):500-9. doi: 10.1016/j.vaccine.2006.07.055. Epub 2006 Aug 17. Vaccine. 2007. PMID: 16996662 Free PMC article.
-
Infertility in mice induced by the rhesus monkey chorionic gonadotropin beta-subunit glycoprotein (rmCGbeta) using DNA immunization.Mol Cell Biochem. 2002 Feb;231(1-2):89-96. doi: 10.1023/a:1014408713826. Mol Cell Biochem. 2002. PMID: 11952170
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials